KDIGO 2021 慢性肾脏病血压管理临床实践指南执行摘要
KDIGO 2021 指南更新了未接受透析的 CKD 患者血压管理推荐,基于系统评价和 GRADE 方法,新增标准化血压测量章节。根据 SPRINT 等证据,建议多数未透析 CKD 患者诊室收缩压目标低于 120 mm Hg(儿童和肾移植受者除外)。
要点
- 多数未透析 CKD 患者收缩压目标<120 mm Hg(标准化诊室测量)。
- 儿童和肾移植受者不适用该目标。
- 强调标准化血压测量,新增专门章节。
核心结论
- 推荐多数未透析 CKD 患者诊室收缩压目标<120 mm Hg。
研究设计与样本
- 指南更新基于系统评价和 GRADE 方法制定。
主要发现
- 根据 SPRINT 等证据,多数未透析 CKD 患者收缩压目标<120 mm Hg,儿童和肾移植受者除外。
关键数值与推荐
- 推荐多数未透析 CKD 患者诊室收缩压目标<120 mm Hg(标准化诊室测量)。
- 儿童和肾移植受者不适用该目标。
临床怎么用
- 临床应采用标准化诊室血压测量,对多数未透析 CKD 患者以收缩压<120 mm Hg 为目标。
局限性
- 证据局限性在指南中有所考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease for patients not receiving dialysis represents an update to the KDIGO 2012 guideline on this topic. Development of this guideline update followed a rigorous process of evidence review and appraisal. Guideline recommendations are based on systematic reviews of relevant studies and appraisal of the quality of the evidence. The strength of recommendations is based on the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) approach. The scope includes topics covered in the original guideline, such as optimal blood pressure targets, lifestyle interventions, antihypertensive medications, and specific management in kidney transplant recipients and children. Some aspects of general and cardiovascular health, such as lipid and smoking management, are excluded. This guideline also introduces a chapter dedicated to proper blood pressure measurement since all large randomized trials targeting blood pressure with pivotal outcomes used standardized preparation and measurement protocols adhered to by patients and clinicians. Based on previous and new evidence, in particular the Systolic Blood Pressure Intervention Trial (SPRINT) results, we propose a systolic blood pressure target of less than 120 mm Hg using standardized office reading for most people with chronic kidney disease (CKD) not receiving dialysis, the exception being children and kidney transplant recipients. The goal of this guideline is to provide clinicians and patients a useful resource with actionable recommendations supplemented with practice points. The burden of the recommendations on patients and resources, public policy implications, and limitations of the evidence are taken into consideration. Lastly, knowledge gaps and recommendations for future research are provided.
引用
- Cheung AK, Chang TI, Cushman WC, et al. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021. PMID: 33637203. doi:10.1016/j.kint.2020.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。